Related Experiment Videos
Recurrent papilloedema and early onset optic atrophy in Behçet's syndrome
L S Teh1, G M O'Connor, M M O'Sullivan
1Department of Rheumatology, University Hospital of Wales, Heath Park, Cardiff.
Annals of the Rheumatic Diseases
|June 1, 1990
Summary
Two Behçet's syndrome patients with intracranial hypertension experienced different outcomes. One recovered fully from recurrent papilloedema, while the other developed irreversible optic atrophy despite treatment.
Area of Science:
- Neurology
- Ophthalmology
- Rheumatology
Background:
- Behçet's syndrome is a rare multisystem inflammatory disorder.
- Intracranial hypertension can be a serious complication of Behçet's syndrome.
Observation:
- This report details two cases of Behçet's syndrome presenting with intracranial hypertension.
- One patient experienced recurrent papilloedema (optic nerve swelling) during treatment.
Findings:
- Despite treatment, one patient fully recovered from papilloedema.
- The second patient developed optic atrophy (irreversible vision loss) within three months of disease onset.
Implications:
- These cases highlight the variable neurological and visual prognosis in Behçet's syndrome patients with intracranial hypertension.
- Prompt diagnosis and management are crucial to prevent severe visual impairment.